Biotech | April 28, 2022
USFDA grants Breakthrough Device designation to Nocria’s Migraine treatment
Nocria’s hand-held device uses gentle, controlled puffs of air in the ears for treating migraine attacks
Nocria’s hand-held device uses gentle, controlled puffs of air in the ears for treating migraine attacks
Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company's global growth journey
An RMAT confers eligibility for accelerated approval and priority review of biologics licensing applications (BLA)
The fund has already invested in seven companies including Medikabazaar, THB, Impact Guru, Stanplus, Ekincare, Qure.ai and HealthifyMe
BVX-0922 to target colorectal cancer under investigator-sponsored IND
The implementation of ScienceMedia's solutions will ultimately help AMCR collapse patient recruitment and enrollment
Cabenuva was co-developed as part of a collaboration with ViiV Healthcare and builds on Janssen's decades-long commitment to combatting HIV
Sputnik Light is the first component of Sputnik V
Clinical surveillance solution is designed to identify emergent patient deterioration and offer enhanced patient data visibility, flexible viewing options, and clinical decision support
Scientists worldwide have started employing wastewater analysis as an efficient and cost-effective approach for assessing the dynamics of the virus in a population. Several scientific methods are being developed to rapidly decode the message carried by sewage
Subscribe To Our Newsletter & Stay Updated
